MENSTRUAL SIKL BUZILISHLARINING ASOSIY SABABLARI VA SKRINING (TEKSHIRUV) ALGORITMI
pdf (Узбекский)

Ключевые слова

Menstrual sikl, menstrual sikl buzilishlari, amenoreya, oligomenoreya, polimenoreya, menorragiya, dismenoreya, polikistoz tuxumdonlar sindromi, endokrin buzilishlar, giperprolaktinemiya, qalqonsimon bez disfunksiyasi, gipotalamik amenoreya, gormonal profil, skrining algoritmi, transvaginal ultratovush, FSH, LH, TSH, prolaktin, AMH, reproduktiv salomatlik, differensial diagnostika.

Аннотация

Mazkur maqolada ayollarda menstrual sikl buzilishlarining asosiy etiologik omillari va ularni erta aniqlashga qaratilgan zamonaviy skrining algoritmi tahlil qilingan.

Tadqiqotda menstrual sikl buzilishlarining endokrin, anatomik, genetik va funksional sabablari, xususan, polikistoz tuxumdonlar sindromi, qalqonsimon bez disfunksiyasi, giperprolaktinemiya, gipotalamik amenoreya, bachadon miomasi, endometrioz va poliplar o‘rganilgan. Diagnostik jarayonda anamnestik ma’lumotlarni yig‘ish, klinik ko‘rik, gormonal profil, transvaginal ultratovush tekshiruvi hamda zaruratga ko‘ra chuqurlashtirilgan instrumental tekshiruvlardan foydalanish imkoniyatlari yoritilgan. Tadqiqot natijalari menstrual sikl buzilishlari etiologiyasida endokrin omillar ustunligini ko‘rsatgan.

Taklif etilgan bosqichma-bosqich skrining algoritmi polikistoz tuxumdonlar sindromi va qalqonsimon bez patologiyalarini aniqlashda yuqori sezgirlik va o‘ziga xoslik ko‘rsatkichlarini namoyon etgan hamda diagnostika jarayonini optimallashtirish imkonini bergan. Tadqiqot natijalari menstrual sikl buzilishlarini erta aniqlash, ortiqcha tekshiruvlarning oldini olish va individual davolash taktikasini belgilashda kompleks skrining yondashuvining amaliy ahamiyatini ko‘rsatadi.

pdf (Узбекский)

Библиографические ссылки

Smith L., et al. Prevalence and impact of menstrual disorders. J Clin Endocrinol Metab. 2020;105(3):e123-e135.

Azziz R., et al. Polycystic ovary syndrome: a global perspective. Fertil Steril. 2018;110(7):1241-1250.

Teede H.J., et al. Recommendations for the diagnosis and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-1618.

Krassas G.E., et al. Thyroid function and menstrual cycle. Eur J Endocrinol. 2019;181(4):R101-R112.

Melmed S., et al. Diagnosis and management of hyperprolactinemia. J Clin Endocrinol Metab. 2011;96(2):273-288.

Gordon C.M., et al. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(5):1413-1439.

Munro M.G., et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3-13.

Nelson L.M. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606-614.

American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 136: Abnormal uterine bleeding. Obstet Gynecol. 2013;122(1):173-181.

Goodman N.F., et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause. Endocr Pract. 2011;17 Suppl 6:1-25.

Dewailly D., et al. Definition and significance of polycystic ovarian morphology in adolescents. Hum Reprod Update. 2014;20(3):334-352.